← Back to Search

Standard Postpartum Care for Prophylaxis of Preeclampsia

Phase 4
Waitlist Available
Led By Richard Lee, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48, 72 and 96 hours postpartum
Awards & highlights

Summary

This trial will determine whether postpartum standard care withholding NSAID use is associated with a clinically significant reduction in postpartum hypertension in women with pregnancy induced hypertension.

Eligible Conditions
  • Prophylaxis of Preeclampsia
  • Hypertension
  • Pre-eclampsia
  • Hypertension in Pregnancy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48, 72 and 96 hours postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48, 72 and 96 hours postpartum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Initiation of anti-hypertensive medication
Length of hospital stay
Number of participants with eclamptic Seizure
+5 more

Trial Design

2Treatment groups
Active Control
Group I: Standard Postpartum CareActive Control1 Intervention
Subjects will receive NSAIDs (e.g. ibuprofen, ketorolac) for routine postpartum pain management.
Group II: Standard Postpartum Care without NSAIDsActive Control1 Intervention
Subjects will receive standard postpartum care without NSAID administration for pain management. Acetaminophen or narcotics will be substituted for ibuprofen as indicated by provider.

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
936 Previous Clinical Trials
1,613,281 Total Patients Enrolled
Richard Lee, MDPrincipal InvestigatorUniversity of Southern California
5 Previous Clinical Trials
1,264 Total Patients Enrolled
~30 spots leftby Sep 2025